By

Vaxart, Inc., a privately held, clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced positive results demonstrating...

By

Vaxart, Inc., a privately held, clinical-stage company developing vaccines that are administered by tablet rather than by injection, Sunday announced that The Lancet Infectious Diseases published an article...

The bivalent Norovirus GII.4 oral tablet vaccine developed by Vaxart is moving forward–the initiation of a Phase 1b clinical trial. “The initiation of the bivalent norovirus vaccine Phase 1b trial...

Vaxart, Inc. a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced publication of the comprehensive results of...

Vaxart, Inc., a privately-held, clinical stage biotechnology company developing oral recombinant vaccines administered by tablet rather than by injection, announced today that its H1 influenza oral tablet...

Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced Tuesday that its norovirus tablet vaccine met...

Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced Tuesday the initiation of a Phase 1 clinical...

Norovirus. That nasty little bug most commonly associated with cruise ship outbreaks is quite costly, in medical, economic and societal terms. Norovirus kills 200,000 globally annually, while Bartsch...

Vaxart, Inc., a clinical stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced today it has initiated preclinical testing...

By

California Department of Public Health (CDPH) Director and State Public Health Officer Dr. Karen Smith today announced that California is experiencing an increase in norovirus cases, commonly referred...